Selective oestrogen receptor modulation: molecular pharmacology for the millennium (Q33837314)

29 July 2017

1 reference

title

Selective oestrogen receptor modulation: molecular pharmacology for the millennium (English)

1 reference

29 July 2017

1 reference

1 reference

2

Jordan VC

1 reference

29 July 2017

Levenson AS

1

1 reference

29 July 2017

publication date

1 November 1999

1 reference

European Journal of Cancer

29 July 2017

published in

1 reference

29 July 2017

volume

35

1 reference

29 July 2017

issue

12

1 reference

29 July 2017

page(s)

1628-1639

1 reference

A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

A receptor molecule for estrogens: studies using a cell-free system

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

A two-step mechanism for the interaction of estradiol with rat uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Remodeling the estrogen receptor model

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Estrogen receptor as a target for the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Tamoxifen: the herald of a new era of preventive therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

1 reference

7 January 2021

A new derivative of triphenylethylene: effect on implantation and mode of action in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Implications of tamoxifen metabolism in the athymic mouse for the study of antitumor effects upon human breast cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Anti-oestrogenic and anti-tumour properties of prolonged tamoxifen therapy in C3H/OUJ mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Effects of anti-estrogens on bone in castrated and intact female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Sequence and expression of human estrogen receptor complementary DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

ER beta: identification and characterization of a novel human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Exploring the role of sex steroids through studies of receptor deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Functional domains of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Characterization of the Amino-terminal Transcriptional Activation Function of the Human Estrogen Receptor in Animal and Yeast Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Ligand-independent activation of steroid hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

The human estrogen receptor has two independent nonacidic transcriptional activation functions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Identification of two transactivation domains in the mouse oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

RIP-140 interacts with multiple nuclear receptors by means of two distinct sites

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Interaction of proteins with transcriptionally active estrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Interaction of steroid hormone receptors with the transcription initiation complex

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Estrogen receptors alpha and beta form heterodimers on DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Selective estrogen receptor modulators: a look ahead

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Nuclear receptor coactivators and corepressors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

The nuclear receptor ligand-binding domain: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

p300 is a component of an estrogen receptor coactivator complex

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Role of CBP/P300 in nuclear receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Steroid receptor coactivator-1 is a histone acetyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

A MOLECULAR THEORY OF DRUG ACTION BASED ON INDUCED CONFORMATIONAL PERTURBATIONS OF RECEPTORS

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Mechanisms of antihormone action

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Polarity-specific activities of retinoic acid receptors determined by a co-repressor.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

A transcriptional co-repressor that interacts with nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Effects of raloxifene hydrochloride on the endometrium of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Correction: raloxifene response needs more than an element

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Droloxifene, a new antiestrogen: its role in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

A non-steroidal estrogen antiagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Tamoxifen, raloxifene, and the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900183-5

7 January 2021

Hormone Receptors: Studies on the Interaction of Estrogen with the Uterus

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1016/B978-1-4831-9827-9.50008-3

10.1016/S0959-8049(99)00183-5

30 August 2024

Identifiers

DOI

1 reference

29 July 2017

1 reference